EGFR and non-small cell lung carcinoma: In NSCLC, somatic mutations in the TK domain of EGFR cause its constitutive activation along with its downstream signaling molecules through phosph-Akt even in the absence of ligand, leading to sustained proliferation, invasion and metastasis [143].